Tetsuo Takuma
Kawasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
Journal: Journal of medical virology
Published: April 22, 2023
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Journal: Internal medicine (Tokyo, Japan)
Published: August 09, 2022
Heterogeneity assessment of vaccine-induced effects using point-of-care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2.
Journal: Journal of clinical laboratory analysis
Published: March 07, 2022
Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Journal: Internal medicine (Tokyo, Japan)
Published: November 08, 2021
Effects of 1-year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: June 17, 2021
Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study.
Journal: Diabetes technology & therapeutics
Published: February 05, 2020
A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes.
Journal: Journal of clinical medicine research
Published: January 29, 2020
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.
Journal: Journal of diabetes investigation
Published: December 06, 2019
Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine research
Published: August 14, 2019
Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.
Journal: Journal of clinical medicine research
Published: November 02, 2018
Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study.
Journal: Journal of clinical medicine research
Published: May 25, 2017
Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine research
Published: April 11, 2017
Last Updated: 09/26/2026